➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
McKesson
Harvard Business School
Dow
Boehringer Ingelheim

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2011)

Docket   Start Trial Date Filed 2011-04-21
Court District Court, D. New Jersey Date Terminated 2017-07-21
Cause 35:271 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Douglas E. Arpert
Parties ACTAVIS LABORATORIES FL, INC.; ACTAVIS PHARMA, INC.; ANCHEN PHARMACEUTICALS, INC.; ASTRAZENECA AB; ASTRAZENECA LP; DR. REDDY'S LABORATORIES INC.; DR. REDDY'S LABORATORIES LTD.; GARRETT BROWN, JR.; HORIZON PHARMA, INC.; KBI-E INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; MYLAN LABORATORIES LIMITED; MYLAN PHARMACEUTICALS; MYLAN, INC.; PHV SHANNON M. BLOODWORTH; POZEN INC.; POZEN, INC.; WATSON PHARMA, INC.
Patents 6,369,085; 6,875,872; 6,926,907; 7,411,070; 7,745,466; 8,557,285
Attorneys AARON HENRY GOULD; ALAN HENRY POLLACK; ALLISON LINDA HOLLOWS; CARISSA L. RODRIGUE; CHRISTINE INTROMASSO GANNON; CHRISTOPHER ROBERT KINKADE; DMITRY V. SHELHOFF; ELINA SLAVIN; ERICA SUSAN HELMS; GARRETT E. BROWN , JR.; GREGORY D. MILLER; GUILLERMO CARLO ARTILES; JAMES S. RICHTER; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; KRISTEN HEALEY CRAMER; LIZA M. WALSH; MARK H. ANANIA; NANCY ANN DEL PIZZO; RAVIN R. PATEL; ROBERT JOSEPH FETTWEIS; SARAH CHRISTINE MITCHELL; SEAN R. KELLY; SELINA MIRIAM ELLIS; STEPHEN J. SMITH; STUART D. SENDER; SYMONE J. REDWINE
Firms Budd Larner, P.C.; Budd Larner, PC; Connell, Foley; Fleming Ruvoldt PLLC; Fox Rothschild LLP; Fox Rothschild LLP, Pc; Jams; McCarter & English, LLP; McCarter and English, LLP; Rivkin Radler LLP; Saiber, LLC; Saul Ewing Arnstein & Lehr LLP; Schiff Hardin LLP; Tressler LLP; Winston and Strawn LLP; Womble Bond Dickinson (US) LLP
Link to Docket External link to docket
Small Molecule Drugs cited in HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-08-30 100 U.S. Patent No. 7,411,070 (“the ’070 patent”), and U.S. Patent No. 7,745,466 (“the ’466 patent”). Anchen…11 C. U.S. Patent Nos. 6,369,085, 7,411,070, and 7,745,466............................….................... 1, 11, 13, 14 U.S. Patent No. 7,745,466 ........................................…terms. C. U.S. Patent Nos. 6,369,085, 7,411,070, and 7,745,466 1. “magnesium…of U.S. Patent No. 6,926,907 (“the ’907 patent”), U.S. Patent No. 6,369,085 (“the ’085 patent”), U.S. External link to document
2012-08-30 101 Nos. 6,926,907; 6,369,085; 7,411,070; and 7,745,466. AstraZeneca holds approved New Drug Application…four patents related to AstraZeneca’s drug product Vimovo®. The patents-in-suit are U.S. Patent Nos.…trihydrate” (’085 Patent, Claims 1–4 and 12; ’070 Patent, Claims 1–4; and ’466 Patent, Claims … 1 of the ’085 Patent and claim 3 of the ’466 Patent, and Table 1 of both patents provide peak positions…trihydrate” (’085 Patent, Claims 1–4 and 12; ’070 Patent, Claims 1–4; and External link to document
2012-09-27 105 U.S. Patent No. 7,411,070 (“the ’070 patent”), and U.S. Patent No. 7,745,466 (“the ’466 patent”) (collectively…........11 IV. U.S. Patent Nos. 6,369,085, 7,411,070, and 7,745,466 ...........................…PageID: 3357 IV. U.S. PATENT NOS. 6,369,085, 7,411,070, AND 7,745,466 A. “magnesium…of U.S. Patent No. 6,926,907 (“the ’907 patent”), U.S. Patent No. 6,369,085 (“the ’085 patent”), U.S.… regard to the ’085, ’070 and ’466 patents (the “trihydrate patents”), Plaintiffs’ construction of the External link to document
2013-05-01 142 the “ ‘070 patent”), No. 7,745,466 (the “ ‘466 patent”), No. 5,714,504 (the “ ‘504 patent”) and 6,875,872… of the patents, specifically, the’504 patent, ‘872 patent, ‘085 patent and ‘070 patent, have been … There are six patents-in-suit. The ‘085 patent, the ‘070 patent and the ‘466 patent relate to esomeprazole…of the ‘070 patent (or ‘466 patent).” ‘504 and ‘872 Patents The ’872 patent claims the …infringement of U.S. Patent No. 6,926,907 (the “ ‘907 patent”), No. 6,369,085 (the “ ‘085 patent”), No. 7,411,070 External link to document
2013-05-01 143 claim terms in U.S. Patent No. 6,926,907, No. 6,369,085, No. 7,411,070, No. 7,745,466, No. 5,714,504 and…2011 21 July 2017 3:11-cv-02317 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Dow
Colorcon
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.